Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Patricia L. Allen currently holds 18,500 shares of Deciphera Pharmaceuticals, Inc. (DCPH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Patricia L. Allen has been a net seller of DCPH stock. They have purchased $49.9K and sold $3.4M worth of shares.
Patricia L. Allen's most recent insider trade was on Jun 15, 2026, when they sold 18,500 shares at $0.00 per share.
Patricia L. Allen serves as Executive at Deciphera Pharmaceuticals, Inc. (DCPH). They have executed 75 insider transactions totaling $3.5M over their tenure at the company.
Patricia L. Allen holds the position of Executive at Deciphera Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Patricia L. Allen has shown a selling trading pattern, with $49.9K in total purchases and $3.4M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Patricia L. Allen was on Jan 24, 2020, when they sold $1.2M worth of DCPH shares. This transaction involved 17,804 shares at $65.93 per share.
Patricia L. Allen currently owns 18,500 shares of Deciphera Pharmaceuticals, Inc. (DCPH), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Patricia L. Allen's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Patricia L. Allen has 75 Form 4 filings on record as an insider at Deciphera Pharmaceuticals, Inc..
Set alerts for Patricia L. Allen and 40,000+ other insiders.